Your browser doesn't support javascript.
loading
Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits.
Whyte, Carly E; Singh, Kailash; Burton, Oliver T; Aloulou, Meryem; Kouser, Lubna; Veiga, Rafael Valente; Dashwood, Amy; Okkenhaug, Hanneke; Benadda, Samira; Moudra, Alena; Bricard, Orian; Lienart, Stephanie; Bielefeld, Pascal; Roca, Carlos P; Naranjo-Galindo, Francisco José; Lombard-Vadnais, Félix; Junius, Steffie; Bending, David; Ono, Masahiro; Hochepied, Tino; Halim, Timotheus Y F; Schlenner, Susan; Lesage, Sylvie; Dooley, James; Liston, Adrian.
Affiliation
  • Whyte CE; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Singh K; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Burton OT; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Aloulou M; VIB Center for Brain and Disease Research, Vlaams Instituut voor Biotechnologie, Leuven, Belgium.
  • Kouser L; Department of Microbiology, Immunology and Transplantation, KU Leuven-University of Leuven, Leuven, Belgium.
  • Veiga RV; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Dashwood A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), Centre national de la recherche scientifique U5051, Institut national de la santé et de la recherche médicale U1291, University of Toulouse III, Toulouse, France.
  • Okkenhaug H; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Benadda S; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Moudra A; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Bricard O; Imaging Facility, The Babraham Institute, Cambridge, UK.
  • Lienart S; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Bielefeld P; Centre de Recherche Sur L'inflammation, Centre national de la recherche scientifique ERL8252, Institut national de la santé et de la recherche médicale U1149, Université de Paris, Paris, France.
  • Roca CP; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Naranjo-Galindo FJ; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Lombard-Vadnais F; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Junius S; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Bending D; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Ono MM; Immunology Programme, The Babraham Institute, Cambridge, UK.
  • Hochepied T; Department of Microbiology and Immunology, McGill University, Montréal, Quebec, Canada.
  • Halim TYF; Department of Immunology-Oncology, Maisonneuve-Rosemont Hospital, Montréal, Quebec, Canada.
  • Schlenner S; VIB Center for Brain and Disease Research, Vlaams Instituut voor Biotechnologie, Leuven, Belgium.
  • Lesage S; Department of Microbiology, Immunology and Transplantation, KU Leuven-University of Leuven, Leuven, Belgium.
  • Dooley J; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Liston A; Department of Life Sciences, Imperial College London, London, UK
J Exp Med ; 219(7)2022 07 04.
Article in En | MEDLINE | ID: mdl-35699942
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Interleukin-2 / T-Lymphocytes, Regulatory Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Exp Med Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Interleukin-2 / T-Lymphocytes, Regulatory Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Exp Med Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: United States